Moleculera Biosciences Physician Testimonials
Dr. Richard Horowitz
“The Panel is fortunately a great tool for doctors to look at these antineuronal antibodies to find out who may be a candidate for IVIG.”
Watch physicians discuss how the Autoimmune Brain Panel (formerly the Cunningham Panel™)
helped in diagnosing and treating patients with immune-mediated neuropsychiatric disorders.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.